Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CTV 05

Drug Profile

CTV 05

Alternative Names: CTV-05; LACTIN-V; Lactobacillus crispatus CTV-05

Latest Information Update: 08 Mar 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GyneLogix
  • Developer National Institute of Allergy and Infectious Diseases; Osel Inc; The Fertility Clinic, Skive; University of Washington
  • Class Probiotics
  • Mechanism of Action Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Urinary tract infections
  • Phase II Bacterial vaginosis

Most Recent Events

  • 22 Feb 2019 National Institute of Allergy and Infectious Diseases completes a phase II trial in Bacterial vaginosis in USA (Vaginal) (NCT02766023)
  • 24 Jun 2018 Biomarkers information updated
  • 11 May 2016 Phase-II clinical trials in Bacterial vaginosis (Prevention, Recurrent) in USA (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top